Interojo Co

Interojo Co Rule of 40

The Rule of 40 of Interojo Co (119610.KQ) as of Nov 20, 2026 is 18.69 %. In the previous year, Rule of 40 was 2.12 % — a change of 780.48% (higher).

Rule of 40

18.69 %

YoY

780.48%

Last updated:

Rule of 40 of Interojo Co is 2025 18.69 % . Rule of 40 of Interojo Co was 2024 2.12 % . It decreases by 780.48% higher compared to the previous year.

The Interojo Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
20.08 KRW
Jan 1, 2019
40.98 KRW
Jan 1, 2020
12.45 KRW
Jan 1, 2021
56.55 KRW
Jan 1, 2022
33.19 KRW
Jan 1, 2023
-1.66 KRW
Jan 1, 2024
2.12 KRW
Jan 1, 2025
18.69 KRW
The Interojo Co Rule of 40 history
YEARRule of 40YoY
18.69 %+780.48%
2.12 %-227.98%
-1.66 %-105.00%
33.19 %-41.32%
56.55 %+354.23%
12.45 %-69.62%
40.98 %+104.02%
20.08 %-49.06%
39.43 %-28.82%
55.39 %-5.21%
58.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Interojo Co Stock analysis

What does Interojo Co do? Interojo Co Ltd manufactures and sells contact lenses including silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, and rigid gas permeable (RGP) contact lenses along with solutions. The company distributes its products in domestic and overseas markets, targeting both retail consumers and healthcare providers who purchase lenses for patient use. Its product range caters to diverse vision correction needs, from standard to specialized medical applications, with solutions supporting lens care and usage. The firm's primary revenue streams come from the sale of contact lenses and associated solutions to customers in both domestic and international markets. Products like silicone hydrogel lenses and RGP contact lenses represent key offerings for everyday wear and specialized vision correction, while therapy and bandage lenses serve medical applications requiring professional oversight. The company's domestic market presence complements its overseas distribution, ensuring broad accessibility across different customer segments. Interojo Co Ltd's business model focuses on direct sales of its comprehensive product portfolio to end-users and healthcare institutions. The company's product lines address various vision correction scenarios, from routine daily use with frequent replacement lenses to advanced medical needs with therapy lenses. By maintaining a diverse range of contact lenses and solutions, the company serves both consumer and professional markets without relying on third-party partnerships or additional services. Interojo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Interojo Co stock

Rule of 40 of Interojo Co is 18.69 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Interojo Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Interojo Co

All Key Metrics — Interojo Co